{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:28Z","timestamp":1792097308961,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"RUSA 2.0 [Policy (TNMulti-Gen), Dept of Edn, GoI]","award":["F. 24-51\/2014-U"],"award-info":[{"award-number":["F. 24-51\/2014-U"]}]},{"name":"CMRG","award":["2023BBT03024"],"award-info":[{"award-number":["2023BBT03024"]}]},{"name":"CMRG","award":["2023BBT03024"],"award-info":[{"award-number":["2023BBT03024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03372-w","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:06:02Z","timestamp":1788843962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Farnesol suppresses hypoxia associated EMT signaling and impairs 3D spheroid integrity in A549 lung adenocarcinoma cells"],"prefix":"10.1007","volume":"43","author":[{"given":"Muthuvenugopal","family":"Nagakanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthivel","family":"Jafni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra Kumar","family":"Soundarya Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behera","family":"Sangita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baskaran","family":"Kailash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidharan Kannan","family":"Srilekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Padmesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasi Pandima","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"3372_CR1","unstructured":"Cancer Today. Accessed: May 20, 2025. [Online]. Available: https:\/\/gco.iarc.who.int\/today\/en\/dataviz\/maps-most-common-sites?mode=cancer&key=total&types=1"},{"issue":"1","key":"3372_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LEL Hendriks","year":"2024","unstructured":"Hendriks LEL, et al. Non-small-cell lung cancer. Nat Reviews Disease Primers. 2024;10(1):1\u201322. https:\/\/doi.org\/10.1038\/s41572-024-00551-9","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"3372_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct Target Therapy. 2025;10(1):1\u201338. https:\/\/doi.org\/10.1038\/s41392-025-02148-4","journal-title":"Signal Transduct Target Therapy"},{"key":"3372_CR4","doi-asserted-by":"publisher","unstructured":"Wang S, Yan Y, Cheng Z, Hu Y, Liu T. Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-\u03b1\/NF-\u03baB and PI3K\/AKT signaling pathway, Cell Death Discovery 2018 4:1, vol. 4, no. 1, pp. 1\u201311, Feb. 2018, https:\/\/doi.org\/10.1038\/s41420-018-0026-9","DOI":"10.1038\/s41420-018-0026-9"},{"key":"3372_CR5","doi-asserted-by":"publisher","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer, Nature Medicine 2021 27:1, vol. 27, no. 1, pp. 34\u201344, Jan. 2021. https:\/\/doi.org\/10.1038\/s41591-020-01195-4","DOI":"10.1038\/s41591-020-01195-4"},{"issue":"19","key":"3372_CR6","doi-asserted-by":"publisher","first-page":"10827","DOI":"10.3390\/IJMS221910827","volume":"22","author":"Y Yang","year":"2021","unstructured":"Yang Y, Li N, Wang TM, Di L Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment. Int J Mol Sci. 2021;22(19):10827. https:\/\/doi.org\/10.3390\/IJMS221910827.","journal-title":"Int J Mol Sci"},{"key":"3372_CR7","doi-asserted-by":"publisher","unstructured":"Fu R et al. Apr., HIF-1\u03b1 promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment, Cell Death & Disease 2021 12:4, vol. 12, no. 4, pp. 1\u201311, 2021, https:\/\/doi.org\/10.1038\/s41419-021-03682-z","DOI":"10.1038\/s41419-021-03682-z"},{"key":"3372_CR8","doi-asserted-by":"publisher","unstructured":"Li W et al. Aug., Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT, SpringerW Li, S Li, L Deng, S Yang, M Li, S Long, S Chen, F Lin, L XiaoTumor Biology, 2015\u2022Springer, vol. 36, no. 9, pp. 6883\u20136889, 2015, https:\/\/doi.org\/10.1007\/S13277-015-3381-7","DOI":"10.1007\/S13277-015-3381-7"},{"key":"3372_CR9","doi-asserted-by":"publisher","unstructured":"Stemmler MP. PCAF, ISX, and BRD4: a maleficent alliance serving lung cancer malignancy. EMBO Rep. Feb. 2020;21:e49766. https:\/\/doi.org\/10.15252\/EMBR.201949766. no. 2.","DOI":"10.15252\/EMBR.201949766"},{"key":"3372_CR10","doi-asserted-by":"publisher","first-page":"1438067","DOI":"10.3389\/FPHAR.2024.1438067\/XML","volume":"15","author":"N Vella","year":"2024","unstructured":"Vella N, Fenech AG, Petroni Magri V 3D cell culture models in research: applications to lung cancer pharmacology. Front Pharmacol. 2024;15:1438067. . https:\/\/doi.org\/10.3389\/FPHAR.2024.1438067\/XML","journal-title":"Front Pharmacol"},{"key":"3372_CR11","doi-asserted-by":"publisher","unstructured":"Rozenberg JM, et al. Biomedical Applications of Non-Small Cell Lung Cancer Spheroids. Front Oncol. Dec. 2021;11:791069. https:\/\/doi.org\/10.3389\/FONC.2021.791069.","DOI":"10.3389\/FONC.2021.791069"},{"issue":"16","key":"3372_CR12","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1158\/0008-5472.CAN-07-0931","volume":"67","author":"JH Joo","year":"2007","unstructured":"Joo JH, Liao G, Collins JB, Grissom SF, Jetten AM. Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response. Cancer Res. 2007;67(16):7929\u201336. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0931","journal-title":"Cancer Res"},{"key":"3372_CR13","doi-asserted-by":"publisher","unstructured":"PARK JS, KWON JK, KIM HR, KIM HJ, KIM BS, JUNG JY. Farnesol induces apoptosis of DU145 prostate cancer cells through the PI3K\/Akt and MAPK pathways. Int J Mol Med. May 2014;33(5):1169\u201376. https:\/\/doi.org\/10.3892\/ijmm.2014.1679.","DOI":"10.3892\/ijmm.2014.1679"},{"issue":"11","key":"3372_CR14","doi-asserted-by":"publisher","first-page":"49372","DOI":"10.7759\/CUREUS.49372","volume":"15","author":"ZHF Hinaz","year":"2023","unstructured":"Hinaz ZHF, Pragya S, Ezhilarasan D, Harini KS Anticancer Potential of Farnesol Against Human Osteosarcoma Saos-2 Cells and Human Colorectal Carcinoma HCT-116 Cells. Cureus. 2023;15(11):49372. https:\/\/doi.org\/10.7759\/CUREUS.49372.","journal-title":"Cureus"},{"key":"3372_CR15","doi-asserted-by":"publisher","unstructured":"Muthuvenugopal N, Behera S, Kumar SRR, Balakrishnan I, Kasi PD. Farnesol induces apoptosis, LC3B\/SQSTM1 mediated regulation of autophagy and downregulates anaerobic Glycolysis through suppression of LDH and PKM in A549 lung adenocarcinoma cells, Medical Oncology 2026 43:3, vol. 43, no. 3, p. 134-, Feb. 2026, https:\/\/doi.org\/10.1007\/s12032-026-03238-1","DOI":"10.1007\/s12032-026-03238-1"},{"key":"3372_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/J.IJBIOMAC.2022.01.093","volume":"202","author":"DJ Balan","year":"2022","unstructured":"Balan DJ, et al. Chitosan based encapsulation increased the apoptotic efficacy of thymol on A549 cells and exhibited non toxic response in swiss albino mice. Int J Biol Macromol. 2022;202:620\u201331. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2022.01.093","journal-title":"Int J Biol Macromol"},{"key":"3372_CR17","doi-asserted-by":"publisher","unstructured":"Kiruthiga C, Jaya Balan D, Jafni S, Anandan DP, Devi KP. Phytol and (\u2013)-\u03b1-bisabolol Synergistically trigger intrinsic apoptosis through redox and Ca2\u2009+\u2009imbalance in non-small cell lung cancer. Biocatal Agric Biotechnol. Feb. 2024;56:103005. https:\/\/doi.org\/10.1016\/J.BCAB.2023.103005.","DOI":"10.1016\/J.BCAB.2023.103005"},{"key":"3372_CR18","doi-asserted-by":"publisher","unstructured":"Huang Phao, et al. Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy. Sci Rep. Dec. 2023;13(1):1\u201314. https:\/\/doi.org\/10.1038\/S41598-023-27580-W;SUBJMETA.","DOI":"10.1038\/S41598-023-27580-W;SUBJMETA"},{"issue":"8","key":"3372_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/MD19080465\/S1","volume":"19","author":"SY Kim","year":"2021","unstructured":"Kim SY, et al Inhibition of a549 lung cancer cell migration and invasion by ent-caprolactin c via the suppression of transforming growth factor-\u03b2-induced epithelial\u2014mesenchymal transition. Mar Drugs. 2021;19(8):465. https:\/\/doi.org\/10.3390\/MD19080465\/S1.","journal-title":"Mar Drugs"},{"key":"3372_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/J.PROCBIO.2022.07.026","volume":"121","author":"M Jeyakumar","year":"2022","unstructured":"Jeyakumar M, et al \u03b1-bisabolol \u03b2-D-fucopyranoside inhibits \u03b2-amyloid (A\u03b2)25\u201335 induced oxidative stress in Neuro-2a cells via antioxidant approaches. Process Biochem. 2022;121:493\u2013503. https:\/\/doi.org\/10.1016\/J.PROCBIO.2022.07.026.","journal-title":"Process Biochem"},{"key":"3372_CR21","doi-asserted-by":"publisher","unstructured":"Kiruthiga C, Niharika K, Devi KP. Phytol and \u03b1-Bisabolol Synergy Induces Autophagy and Apoptosis in A549 Cells and Additional Molecular Insights through Comprehensive Proteome Analysis via Nano LC-MS\/MS, Anticancer Agents Med. Chem., vol. 24, no. 10, pp. 773\u2013788, Jun. 2024, https:\/\/doi.org\/10.2174\/0118715206289038240214102951","DOI":"10.2174\/0118715206289038240214102951"},{"key":"3372_CR22","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3791\/2720","volume":"51","author":"R Foty","year":"2011","unstructured":"Foty R. A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids. J Vis Exp. no. 2011;51:2720. https:\/\/doi.org\/10.3791\/2720.","journal-title":"J Vis Exp"},{"key":"3372_CR23","unstructured":"Kijanska M, Kelm J. In vitro 3D Spheroids and Microtissues: ATP-based Cell Viability and Toxicity Assays, Assay Guidance Manual, Jan. 2016, Accessed: Feb. 24, 2026. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK343426\/"},{"key":"3372_CR24","doi-asserted-by":"publisher","unstructured":"Perrin L, Gligorijevic B. Proteolytic and Mechanical Remodeling of the Extracellular Matrix by Invadopodia in Cancer. Phys Biol. Jan. 2022;20(1). https:\/\/doi.org\/10.1088\/1478-3975\/aca0d8.","DOI":"10.1088\/1478-3975\/aca0d8"},{"issue":"7","key":"3372_CR25","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1073\/PNAS.94.7.3336","volume":"94","author":"M Tsujii","year":"1997","unstructured":"Tsujii M, Kawano S, Dubois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A. 1997;94(7):3336. . https:\/\/doi.org\/10.1073\/PNAS.94.7.3336","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"3372_CR26","doi-asserted-by":"publisher","first-page":"38816","DOI":"10.18632\/ONCOTARGET.5558","volume":"6","author":"Y Pan","year":"2015","unstructured":"Pan Y, et al. Deletion of cyclooxygenase-2 inhibits K-ras\u2013induced lung carcinogenesis. Oncotarget. 2015;6(36):38816. https:\/\/doi.org\/10.18632\/ONCOTARGET.5558.","journal-title":"Oncotarget"},{"key":"3372_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/J.SEMCANCER.2022.03.011","volume":"86","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cao Y The impact of VEGF on cancer metastasis and systemic disease. Semin Cancer Biol. 2022;86:251\u201361. . https:\/\/doi.org\/10.1016\/J.SEMCANCER.2022.03.011.","journal-title":"Semin Cancer Biol"},{"key":"3372_CR28","doi-asserted-by":"publisher","unstructured":"Li X, Li F, Wang F, Li J, Lin C, Du J. Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2. Onco Targets Ther. May 2018;11:2981. https:\/\/doi.org\/10.2147\/OTT.S157613.","DOI":"10.2147\/OTT.S157613"},{"issue":"11","key":"3372_CR29","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3390\/MOLECULES23112827","volume":"23","author":"YY Jung","year":"2018","unstructured":"Jung YY, Hwang ST, Sethi G, Fan L, Arfuso F, Ahn KS Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol. Molecules. 2018;23(11):2827. https:\/\/doi.org\/10.3390\/MOLECULES23112827.","journal-title":"Molecules"},{"key":"3372_CR30","doi-asserted-by":"publisher","unstructured":"Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, Ahn KS. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt\/mTOR pathway. Pharmacol Res. Dec. 2019;150:104504. https:\/\/doi.org\/10.1016\/j.phrs.2019.104504.","DOI":"10.1016\/j.phrs.2019.104504"},{"key":"3372_CR31","doi-asserted-by":"publisher","unstructured":"Yilmaz \u00d6zt\u00fcrk B, Feyzullazade N, Da\u011f \u0130, \u015eengel T. The investigation of in vitro effects of farnesol at different cancer cell lines, Microsc. Res. Tech., vol. 85, no. 8, pp. 2760\u20132775, Aug. 2022, https:\/\/doi.org\/10.1002\/jemt.24125","DOI":"10.1002\/jemt.24125"},{"key":"3372_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2025.118023","volume":"186","author":"H Mahaki","year":"2025","unstructured":"Mahaki H, et al Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights. Biomed Pharmacother. 2025;186:1\u20132. https:\/\/doi.org\/10.1016\/j.biopha.2025.118023.","journal-title":"Biomed Pharmacother"},{"key":"3372_CR33","doi-asserted-by":"publisher","unstructured":"Anjum S, et al. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1\u0251) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome. Ann Diagn Pathol. Feb. 2022;56:151846. https:\/\/doi.org\/10.1016\/J.ANNDIAGPATH.2021.151846.","DOI":"10.1016\/J.ANNDIAGPATH.2021.151846"},{"key":"3372_CR34","doi-asserted-by":"publisher","unstructured":"Wang S, Yan Y, Cheng Z, Hu Y, Liu T. Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-\u03b1\/NF-\u03baB and PI3K\/AKT signaling pathway, Cell Death Discovery 2018 4:1, vol. 4, no. 1, pp. 1\u201311, Feb. 2018, https:\/\/doi.org\/10.1038\/s41420-018-0026-9","DOI":"10.1038\/s41420-018-0026-9"},{"issue":"1","key":"3372_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-11-1\/TABLES\/5","volume":"11","author":"Z long kui Qiao","year":"2013","unstructured":"kui Qiao Z, long Li Y, tao Lu H, liang K, Wang X, Whai Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma. World J Surg Oncol Jan. 2013;11(1):1\u20136. https:\/\/doi.org\/10.1186\/1477-7819-11-1\/TABLES\/5.","journal-title":"World J Surg Oncol Jan"},{"key":"3372_CR36","doi-asserted-by":"publisher","unstructured":"Gao H, Lan X, Li S, Xue Y. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Tumor Biology. May 2017;39(5). https:\/\/doi.org\/10.1177\/1010428317698368\/ASSET\/875265CF-4E13-4D85-9CC9-1F1FD953E839\/ASSETS\/IMAGES\/LARGE\/10.1177_1010428317698368-FIG2.JPG.","DOI":"10.1177\/1010428317698368\/ASSET\/875265CF-4E13-4D85-9CC9-1F1FD953E839\/ASSETS\/IMAGES\/LARGE\/10.1177_1010428317698368-FIG2.JPG"},{"key":"3372_CR37","doi-asserted-by":"publisher","unstructured":"Jung YY, Hwang ST, Sethi G, Fan L, Arfuso F, Ahn KS. Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol. Molecules. Oct. 2018;23(11):2827. https:\/\/doi.org\/10.3390\/molecules23112827.","DOI":"10.3390\/molecules23112827"},{"issue":"4","key":"3372_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/CDT3.120","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang J, Sun W, Cao J, Ma Z. COX-2 in lung cancer: Mechanisms, development, and targeted therapies. Chronic Dis Transl Med. 2024;10(4):281. https:\/\/doi.org\/10.1002\/CDT3.120","journal-title":"Chronic Dis Transl Med"},{"issue":"2","key":"3372_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/ATVBAHA.107.158014","volume":"28","author":"D Vestweber","year":"2008","unstructured":"Vestweber D VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol. 2008;28(2):223\u201332. https:\/\/doi.org\/10.1161\/ATVBAHA.107.158014.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3372_CR40","doi-asserted-by":"publisher","unstructured":"Cha YS, Michaels A, Wang JZ, Niu Y, Lin Y, Zhu L, Zhu X, Wang K, Murray M, Zhou F. Recent advances in 3D cell culture models in cancer drug development, Journal of Pharmaceutical Investigation 2025 55:4, vol. 55, no. 4, pp. 557\u2013573. https:\/\/doi.org\/10.1007\/s40005-025-00740-y","DOI":"10.1007\/s40005-025-00740-y"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03372-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03372-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03372-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:59Z","timestamp":1792096919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03372-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03372-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"269"}}